Diverse sources of C. difficile infection identified on whole-genome sequencing

New England Journal of Medicine

Volumn 369, Issue 13, 2013, Pages 1195-1205

  Eyre, David W ^a,c   Cule, Madeleine L ^b,c   Wilson, Daniel J ^a,d   Griffiths, David ^a,c   Vaughan, Alison ^a,c   O'Connor, Lily ^a,e   Ip, Camilla L C ^b,c   Golubchik, Tanya ^b,c   Batty, Elizabeth M ^c,d   Finney, John M ^a,c   Wyllie, David H ^a,c   Didelot, Xavier ^b,c   Piazza, Paolo ^d   Bowden, Rory ^b,c,d   Dingle, Kate E ^a,c   Harding, Rosalind M ^b,c   Crook, Derrick W ^a,c,e   Wilcox, Mark H ^f   Peto, Tim E A ^a,c,e   Walker, A Sarah ^a,c,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HEALTH CARE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

EID: 84884510020     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1216064     Document Type: Article

References (43)

1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
2. Vonberg R-P, Kuijper EJ, Wilcox MH, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008;14:Suppl 5:2-20. (Pubitemid 351560386)
3. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10. (Pubitemid 19034145)
4. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994;18:181-7. (Pubitemid 24055256)
5. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C. difficile-associated disease. Arch Intern Med 2007;167:1092-7. (Pubitemid 46835798)
6. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166:561-7.
7. Muto CA. Asymptomatic Clostridium difficile colonization: is this the tip of another iceberg? Clin Infect Dis 2007;45:999-1000. (Pubitemid 47580348)
8. Hensgens MPM, Keessen EC, Squire MM, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 2012;18:635-45.
9. Health Protection Agency. Quarterly epidemiological commentary: mandatory MRSA, MSSA and E. coli infection data (up to October-December 2012) (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1284473407318).
10. Walker AS, Eyre DW, Wyllie DH, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 2012;9(2):e1001172.
11. Norén T, Akerlund T, Bäck E, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 2004;42:3635-43. (Pubitemid 39045692)
12. Harbarth S, Samore MH. Clostridium: transmission difficile? PLoS Med 2012;9(2):e1001171.
13. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478-98.
14. Didelot X, Eyre DW, Cule ML, et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol 2012;13(12):R118.
15. Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010;48:770-8.
16. Eyre DW, Walker AS, Griffiths D, et al. Clostridium difficile mixed infection and reinfection. J Clin Microbiol 2012;50:142-4.
17. Bentley DR, Balasubramanian S, Swerdlow HP, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008;456:53-9.
18. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010;31:21-7.
19. Jinno S, Kundrapu S, Guerrero DM, Jury LA, Nerandzic MM, Donskey CJ. Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection. Infect Control Hosp Epidemiol 2012;33:638-9.
20. Rodrigo AG, Felsenstein J. Coalescent approaches to HIV population genetics. In: Crandall KA, ed. Evolution of HIV. Baltimore: Johns Hopkins University Press, 1999:233-72.
21. Health Protection Agency. Results from the mandatory Clostridium difficile reporting scheme, 2012 (http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1195733750761).
22. Bartsch SM, Curry SR, Harrison LH, Lee BY. The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis 2012;31:3163-71.
23. He M, Sebaihia M, Lawley TD, et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 2010;107:7527-32.
24. Stabler RA, Dawson LF, Valiente E, et al. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 2012;7(3):e31559.
25. Loo VG, Bourgault A-M, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693-703.
26. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998;351:633-6. (Pubitemid 28098446)
27. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990;336:97-100. (Pubitemid 20222816)
28. He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013;45:109-13.
29. Wilcox MH, Shetty N, Fawley WN, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 2012;55:1056-63.
30. Annual report of the Chief Medical Officer, 2011. London: Department of Health (https://www.gov.uk/government/uploads/system/uploads/attachment-data/ file/138331/CMO-Annual-Report-Volume-2-2011.pdf).
31. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase- producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2013;41:137-42.
32. Starr JM, Campbell A, Renshaw E, Poxton IR, Gibson GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect 2009;71:49-56.
33. Wyllie DH, Walker AS, Miller R, et al. Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open 2011;1(1):e000160.
34. Stabler RA, He M, Dawson L, et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 2009;10(9):R102.
35. Updated guidance on the diagnosis and reporting of Clostridium difficile. London: Department of Health, March 2012 (http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-132927).
36. Wilcox MH, Planche T. Summary of research underpinning the Department of Health's new Clostridium difficile testing guidance, 2011 (http://www.hpa.org. uk/webc/HPAwebFile/HPAweb-C/1317132979562).
37. Eyre DW, Cule ML, Griffiths D, et al. Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Comput Biol 2013;9(5):e1003059.
38. Miyajima F, Roberts P, Swale A, et al. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 2011;6(8):e22804.
39. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among longterm care facility residents. Clin Infect Dis 2007;45:992-8. (Pubitemid 47580347)
40. Ozaki E, Kato H, Kita H, et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 2004;53:167-72. (Pubitemid 38223698)
41. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect 2011;63:105-13.
42. Stoesser NE, Martin J, Mawer D, et al. Risk factors for Clostridium difficile acquisition in infants: importance of study design. Clin Infect Dis 2013;56:1680-1.
43. Eyre DW, Golubchik T, Gordon NC, et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2012;2(3):e001124.